GLP-1 and GIP are the hormones behind the world's most talked-about weight-loss drugs — and your gut already produces them after every meal. DPP-IV is the enzyme that switches them off almost immediately. PlantDPP is a plant-derived ingredient designed to get in its way.
The whole cycle takes minutes. Step four is the one most people have never heard of — and it's where this entire story lives.
Food arrives in your small intestine.
Specialized cells release hormones called incretins — GLP-1 and GIP.
Insulin is released, the liver slows sugar output, and the brain registers fullness.
An enzyme called DPP-IV destroys those hormones within minutes.
Made by sensor cells scattered through your gut lining, released within minutes of eating. The blockbuster weight-loss drugs are engineered copies of GLP-1 — your body makes the real thing after every meal.
Dipeptidyl Peptidase-4 — the name is the job description. It snips exactly two amino acids off the end of a protein chain, wherever the second bead is alanine or proline.
GLP-1's chain — position two is alanine, so DPP-IV cuts here. Once those first two beads are gone, the hormone no longer fits its receptor. It still exists — it just stops working.
DPP-IV isn't released in response to your meal — it's built into cell surfaces throughout your body, all the time: gut lining, kidneys, blood vessels, liver, immune cells. On T-cells it's better known as CD26. Standing infrastructure, not a response — which is exactly why a gentle, food-based slowdown makes more sense than a hard blockade.
There are two very different ways to work with this system.
A laboratory-built copy of GLP-1 is injected. It's deliberately redesigned so DPP-IV can't cut it — so it lasts for days instead of minutes.
Instead of adding a copy, get in the way of DPP-IV so the hormone your body already made survives longer.
A group of tiny protein fragments — peptides — made from spirulina, shaped so DPP-IV grabs them instead of grabbing your hormones. These peptides don't exist in ordinary spirulina powder; they're created during manufacturing.
A protein-rich algae eaten as food for decades.
Long chains, folded up. Not active this way on their own.
An enzyme snips the chains into thousands of short fragments.
Only the smallest, most useful fragments are kept.
A dried powder standardized by how well it blocks the enzyme.
This is the single most important thing to understand about why a food-based ingredient could work at all. Everything happens in the same few square inches of gut wall.
L-cells and K-cells release the hormones, vagus nerve endings wait to carry the signal, and DPP-IV sits anchored on the gut surface — all in the same wall.
It has to survive digestion, cross the gut wall, get past the liver, and still be present in useful amounts. Most of it never makes it.
It's already where it needs to be the moment the capsule opens — at its highest concentration, in direct contact with the enzyme it's meant to slow down.
Being straight about this: everything proven to date is in test tubes and animals. Promising — but not the same as proven in people.
Spirulina peptides measurably block DPP-IV — shown by several independent research groups.
Individual active fragments have been isolated and their sequences read.
Oral dosing lowered fasting blood sugar and improved glucose tolerance in diabetic mice.
Digestion appears to improve, not destroy, the activity — encouraging for an oral product.
Not yet done — for this ingredient or any of its type. This is the gap the planned clinical study is designed to fill.
Sensor cells in your gut wall detect food and release two hormones — GIP from the upper gut, GLP-1 from further down.
These hormones are why swallowing sugar triggers far more insulin than injecting it — they do 40–65% of the work.
An enzyme called DPP-IV snips two amino acids off each hormone and switches it off within minutes.
It can do that because both hormones carry the same amino acid in position two. Destroying them is a side effect of a general-purpose tool.
Slow DPP-IV down, and your own hormones last longer — no injection, nothing artificial added.
PlantDPP is a set of spirulina-derived peptides shaped to get in the enzyme's way, created during manufacturing rather than extracted.
Taken with a meal, a swallowed capsule delivers them straight to the gut wall — the exact place hormones are released and destroyed.
Laboratory and animal evidence is encouraging. Human evidence doesn't exist yet — and producing it is the point of the plan.
Because the two-minute lifespan describes a single molecule, not the whole signal. Your gut keeps releasing more GLP-1 and GIP for as long as food is moving through — often an hour or two. Slowing the destruction side shifts the balance up, without making any more hormone. GLP-1 is also only one voice in the chorus: stomach stretch, PYY, CCK, dropping ghrelin, and slower stomach emptying all contribute to feeling full.
No. PlantDPP is positioned for people who are not on GLP-1 drugs, or who are transitioning off them — not as an add-on to active prescription therapy. The injectable drugs are engineered to resist DPP-IV, so slowing DPP-IV down has no effect on them.
The hormones, the nerve endings that respond to them, and most of the DPP-IV that destroys them are all concentrated in the same few square inches of gut wall. A swallowed capsule delivers its contents directly into that space — at its highest concentration, in direct contact with the enzyme — without needing to survive digestion, cross the gut wall, or circulate through the blood in meaningful amounts.
Test-tube inhibition of DPP-IV by spirulina-derived peptides, identification of the active fragments, and favorable results in oral animal studies. No human clinical study of this ingredient — or any ingredient of its type — has been completed yet. That study is the point of the plan, and everything about expected effects in people remains a hypothesis until it reads out.
The investor overview covers market opportunity, business model, capital requirements, and illustrative projections. Access requires a password provided by NewCo.